BioSpace News Archive

There are various challenges at a job that many people ignore just because they fear losing these jobs. Here are some signs you need a new job any delay.

AcelRx Pharmaceuticals plans to resubmit the NDA for Dsuvia in the second quarter of this year.

MyoKardia Inc. revealed positive results from a mid-stage obstructive hypertrophic cardiomyopathy trial.

Avoid these top three roadblocks during the job search process

Xeris Pharmaceuticals secured $45 million in a Term Loan and Securities Agreement with Silicon Valley Bank and Oxford Finance, as well as closing a Series C financing with an additional $10 million.

Voyager Therapeutics released longer-term data from its ongoing Phase Ib clinical trial of VY-AADC in advanced Parkinson’s disease.

Abiomed, Inc. will pay the U.S. government $3.1 million to settle allegations that the company sought to influence doctors to use the company’s line of heart pumps in a kickback scheme.

Martin Shkreli’s actions were brash and often bizarre, but served as a catalyst for the pharma pricing debate.

X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs to improve immune cell trafficking to treat cancer and rare disease, today announced that Paula Ragan, PhD, President and Chief Executive Officer, will present at the Cowen and Company 38th Annual Health Care Conference in Boston on Wednesday, March 14, 2018, at 8:00 a.m. Eastern time.

Eli Lilly and Company (NYSE: LLY) today announced that Maura Dickler, M.D., a prestigious breast cancer researcher, will join Lilly Oncology as Vice President of Late Phase Development on May 7, 2018.